Marie Decraecker

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Machine Learning

Chronic Myeloid Leukemia

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Journal of hepatocellular carcinoma

This page only lists publications with an associated author ORCID identifier.

Publications

Marie Decraecker, Dan Dutartre, Jean-Baptiste Hiriart, Marie Irles-Depé, Faiza Chermak, Juliette Foucher, Victor De Ledinghen
Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods. Alimentary pharmacology & therapeutics 55 (5) (2022)
Marie Decraecker
Editorial: MAFLD and outcome prediction-author's reply. Alimentary pharmacology & therapeutics 55 (6) (2022)
Marie Decraecker, Dan Dutartre, Jean-Baptiste Hiriart, Marie Irles-Depé, Hortense Marraud des Grottes, Faiza Chermak, Juliette Foucher, Adèle Delamarre, Victor De Ledinghen
Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use. Liver international : official journal of the International Association for the Study of the Liver (2021)
Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc
Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib. Cancers 13 (24) (2021)
Audrey Debaillon Vesque, Marie Decraecker, Jean-Frédéric Blanc
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations. Journal of hepatocellular carcinoma 7 (2020)